| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.006 | 0.8 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.8 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.8 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |